These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 17717667

  • 21. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
    Reck M, Macha HN, Del Barco S, Cornes P, Vaissière N, Morand M, Riggi M, Abratt R.
    Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
    [Abstract] [Full Text] [Related]

  • 22. Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer.
    Fujita A, Takabatake H, Tagaki S, Sekine K.
    Cancer Chemother Pharmacol; 2000 Jun; 45(4):279-83. PubMed ID: 10755315
    [Abstract] [Full Text] [Related]

  • 23. Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study.
    Carabante-Ocón F, Cobo-Dols M, Benavides-Orgaz M, Gil-Calle S, Alés-Díaz I, Bretón-García JJ, Villar-Chamorro E, Montesa-Pino A, Alcalde-García J, Gutiérrez-Calderón V.
    Clin Lung Cancer; 2005 Sep; 7(2):121-6. PubMed ID: 16179099
    [Abstract] [Full Text] [Related]

  • 24. Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbine.
    Stupp R, Bodmer A, Duvoisin B, Bauer J, Perey L, Bakr M, Ketterer N, Leyvraz S.
    Oncology; 2001 Sep; 61 Suppl 1():35-41. PubMed ID: 11598413
    [Abstract] [Full Text] [Related]

  • 25. Phase I/II study of vinorelbine, mitomycin, and cisplatin for stage IIIB or IV non-small-cell lung cancer.
    Furuse K, Kawahara M, Nishiwaki Y, Fukuoka M, Takada M, Miyashita M, Ohashi Y.
    J Clin Oncol; 1999 Oct; 17(10):3195-200. PubMed ID: 10506618
    [Abstract] [Full Text] [Related]

  • 26. Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study.
    Beckmann G, Fietkau R, Huber RM, Kleine P, Schmidt M, Semrau S, Aubert D, Fittipaldo A, Flentje M.
    Onkologie; 2006 Apr; 29(4):137-42. PubMed ID: 16601369
    [Abstract] [Full Text] [Related]

  • 27. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Apr; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 28. A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients.
    Yoda S, Soejima K, Yasuda H, Naoki K, Kawada I, Watanabe H, Nakachi I, Satomi R, Nakayama S, Ikemura S, Terai H, Sato T, Morosawa M, Asano K.
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):717-22. PubMed ID: 21152917
    [Abstract] [Full Text] [Related]

  • 29. A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.
    Kosmas C, Tsavaris N, Syrigos K, Koutras A, Tsakonas G, Makatsoris T, Mylonakis N, Karabelis A, Stathopoulos GP, Kalofonos HP.
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):51-9. PubMed ID: 16622691
    [Abstract] [Full Text] [Related]

  • 30. Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
    Katsaounis P, Kotsakis A, Agelaki S, Kontopodis E, Agelidou A, Kentepozidis N, Vamvakas L, Christopoulou A, Karachaliou N, Hatzidaki D, Georgoulias V.
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):821-7. PubMed ID: 25702051
    [Abstract] [Full Text] [Related]

  • 31. Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).
    Bennouna J, Havel L, Krzakowski M, Kollmeier J, Gervais R, Dansin E, Serke M, Favaretto A, Szczesna A, Cobo M, Ciuffreda L, Jassem J, Nicolini M, Ramlau R, Amoroso D, Melotti B, Almodovar T, Riggi M, Caux NR, Vaissière N, Tan EH.
    Clin Lung Cancer; 2014 Jul; 15(4):258-65. PubMed ID: 24954228
    [Abstract] [Full Text] [Related]

  • 32. Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer.
    Goya H, Kuraishi H, Koyama S, Ichiyama T, Yoshiike F, Hirai K, Agatsuma T, Tateishi K, Kanda S, Yamamoto H, Kubo K, Koizumi T.
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):691-7. PubMed ID: 22941346
    [Abstract] [Full Text] [Related]

  • 33. A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC.
    Pallis AG, Chandrinos V, Pavlakou G, Xenidis N, Varthalitis I, Vardakis N, Vamvakas L, Kontopodis E, Rovithi M, Georgoulias V.
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1239-45. PubMed ID: 20697712
    [Abstract] [Full Text] [Related]

  • 34. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
    Jagasia MH, Langer CJ, Johnson DH, Yunus F, Rodgers JS, Schlabach LL, Cohen AG, Shyr Y, Carbone DP, Devore RF.
    Clin Cancer Res; 2001 Jan; 7(1):68-73. PubMed ID: 11205920
    [Abstract] [Full Text] [Related]

  • 35. Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer.
    Mori K, Kamiyama Y, Kondo T, Kano Y, Tominaga K.
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):129-32. PubMed ID: 14605861
    [Abstract] [Full Text] [Related]

  • 36. Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer.
    Takeda K, Negoro S, Kudoh S, Okishio K, Masuda N, Takada M, Tanaka M, Nakajima T, Tada T, Fukuoka M.
    Br J Cancer; 1999 Mar; 79(9-10):1462-7. PubMed ID: 10188891
    [Abstract] [Full Text] [Related]

  • 37. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J.
    Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980
    [Abstract] [Full Text] [Related]

  • 38. Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phase II study.
    Cremonesi M, Mandalà M, Cazzaniga M, Rezzani C, Gambera M, Barni S.
    Oncology; 2003 Apr; 64(2):97-101. PubMed ID: 12566905
    [Abstract] [Full Text] [Related]

  • 39. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
    Bartsch V.
    Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.